Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| OMEROS CORPOMER · Entity 4756 | Director | June 18, 2026 | June 22, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
OMEROS CORP
Report date June 18, 2026 · Filed June 22, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $10.28 · Expires 2036-06-17 | Direct | 15,000 |
Reported balance
After 2026-06-18 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-06-18 · Grant · Acquired 15,000 · Balance 15,000 F1: Pursuant to Omeros Corporation's non-employee director compensation policy, on the date of each annual meeting of shareholders, each non-employee director who has served as a director for at least six months and who will continue to serve as a director after the annual meeting is automatically granted an option to purchase 15,000 shares of common stock. This Form 4 reports the annual stock option award granted to the reporting person in conjunction with the annual meeting of shareholders held on June 18, 2026. F2: This option will fully vest and become exercisable on the day before the date of the 2027 annual meeting of the shareholders of Omeros Corporation, provided that the reporting person continues to serve as a director of the company through such date. |
Filing footnotes · ownership attribution and instrument terms
F1: Pursuant to Omeros Corporation's non-employee director compensation policy, on the date of each annual meeting of shareholders, each non-employee director who has served as a director for at least six months and who will continue to serve as a director after the annual meeting is automatically granted an option to purchase 15,000 shares of common stock. This Form 4 reports the annual stock option award granted to the reporting person in conjunction with the annual meeting of shareholders held on June 18, 2026.
F2: This option will fully vest and become exercisable on the day before the date of the 2027 annual meeting of the shareholders of Omeros Corporation, provided that the reporting person continues to serve as a director of the company through such date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 18, 2026 Filed Jun 22, 2026 11:34 UTC | OMEROS CORP OMER · Entity 4756 | GrantStock Option (Right to Buy) · Derivative | 15,000 | $0.00 Strike: $10.28 | $0.00 |
DisclosureSEC source: 0001437749-26-021238 · rdgdoc.xml · derivative · entry 1 Hood Leroy E. MD PhD · CIK 0001472162 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2036-06-17 F1 · security: Pursuant to Omeros Corporation's non-employee director compensation policy, on the date of each annual meeting of shareholders, each non-employee director who has served as a director for at least six months and who will continue to serve as a director after the annual meeting is automatically granted an option to purchase 15,000 shares of common stock. This Form 4 reports the annual stock option award granted to the reporting person in conjunction with the annual meeting of shareholders held on June 18, 2026. F2 · derivative.exercise_date: This option will fully vest and become exercisable on the day before the date of the 2027 annual meeting of the shareholders of Omeros Corporation, provided that the reporting person continues to serve as a director of the company through such date. Read SEC document |
| June 27, 2025 Filed Jul 1, 2025 21:20 UTC | OMEROS CORP OMER · Entity 4756 | GrantStock Option (Right to Buy) · Derivative | 15,000 | $0.00 Strike: $3.20 | $0.00 |
DisclosureSEC source: 0001437749-25-021795 · rdgdoc.xml · derivative · entry 1 Hood Leroy E. MD PhD · CIK 0001472162 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2035-06-27 F1 · security: Pursuant to Omeros Corporation's non-employee director compensation policy, on the date of each annual meeting of shareholders, each non-employee director who has served as a director for at least six months and who will continue to serve as a director after the annual meeting is automatically granted an option to purchase 15,000 shares of common stock. This Form 4 reports the annual stock option award granted to the reporting person in conjunction with the annual meeting of shareholders held on June 27, 2025. F2 · derivative.exercise_date: This option will fully vest and become exercisable on the day before the date of the 2026 annual meeting of the shareholders of Omeros Corporation, provided that the reporting person continues to serve as a director of the company through such date. Read SEC document |
| June 06, 2024 Filed Jun 7, 2024 21:10 UTC | OMEROS CORP OMER · Entity 4756 | GrantStock Option (Right to Buy) · Derivative | 15,000 | $0.00 Strike: $3.91 | $0.00 |
DisclosureSEC source: 0001437749-24-019709 · rdgdoc.xml · derivative · entry 1 Hood Leroy E. MD PhD · CIK 0001472162 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2034-06-06 F1 · security: Pursuant to Omeros Corporation's non-employee director compensation policy, on the date of each annual meeting of shareholders, each non-employee director who has served as a director for at least six months and who will continue to serve as a director after the annual meeting is automatically granted an option to purchase 15,000 shares of common stock. This Form 4 reports the annual stock option award granted to the reporting person in conjunction with the annual meeting of shareholders held on June 6, 2024. F2 · derivative.exercise_date: This option will fully vest and become exercisable on the day before the date of the 2025 annual meeting of the shareholders of Omeros Corporation, provided that the reporting person continues to serve as a director of the company through such date. Read SEC document |
| June 23, 2023 Filed Jun 27, 2023 23:29 UTC | OMEROS CORP OMER · Entity 4756 | GrantStock Option (Right to Buy) · Derivative | 15,000 | $0.00 Strike: $5.49 | $0.00 |
DisclosureSEC source: 0001415889-23-010374 · form4-06272023_110605.xml · derivative · entry 1 Hood Leroy E. MD PhD · CIK 0001472162 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2033-06-23 F1 · security: Pursuant to Omeros Corporation's non-employee director compensation policy, on the date of each annual meeting of shareholders, each non-employee director who has served as a director for at least six months and who will continue to serve as a director after the annual meeting is automatically granted an option to purchase 15,000 shares of common stock. This Form 4 reports the annual stock option award granted to the reporting person in conjunction with the annual meeting of shareholders held on June 23, 2023. F2 · derivative.exercise_date: This option will fully vest and become exercisable on the day before the date of the 2024 annual meeting of the shareholders of Omeros Corporation, provided that the reporting person continues to serve as a director of the company through such date. Read SEC document |
| September 21, 2022 Filed Sep 24, 2022 00:29 UTC | OMEROS CORP OMER · Entity 4756 | GrantStock Option (Right to Buy) · Derivative | 7,500 | $0.00 Strike: $3.93 | $0.00 |
DisclosureSEC source: 0001415889-22-009931 · form4-09232022_050927.xml · derivative · entry 1 Hood Leroy E. MD PhD · CIK 0001472162 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 7,500 shares Expires 2032-09-21 F1 · derivative.exercise_date: This option will fully vest and become exercisable on the day before the date of the 2023 annual meeting of the shareholders of Omeros Corporation, provided that the participant continues to serve as a director of the company through such date. Read SEC document |
| June 17, 2022 Filed Jun 22, 2022 21:27 UTC | OMEROS CORP OMER · Entity 4756 | GrantStock Option (Right to Buy) · Derivative | 7,500 | $0.00 Strike: $2.00 | $0.00 |
DisclosureSEC source: 0001415889-22-006850 · form4-06222022_020610.xml · derivative · entry 1 Hood Leroy E. MD PhD · CIK 0001472162 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 7,500 shares Expires 2032-06-17 F1 · security: Pursuant to Omeros Corporation's non-employee director compensation policy, on the date of each annual meeting of shareholders, each non-employee director who has served as a director for at least six months and who will continue to serve as a director after the annual meeting is automatically granted an option to purchase 7,500 shares of common stock. This Form 4 reports the annual stock option award granted to the reporting person in conjunction with the annual meeting of shareholders held on June 17, 2022. F2 · derivative.exercise_date: This option will fully vest and become exercisable on the day before the date of the 2023 annual meeting of the shareholders of Omeros Corporation, provided that the participant continues to serve as a director of the company through such date. Read SEC document |
| June 11, 2021 Filed Feb 14, 2022 22:18 UTC | OMEROS CORP OMER · Entity 4756 | GrantStock Option (Right to Buy) · Derivative | 7,500 | $0.00 Strike: $15.81 | $0.00 |
DisclosureSEC source: 0001415889-22-001315 · form4-02142022_020248.xml · derivative · entry 1 Hood Leroy E. MD PhD · CIK 0001472162 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 7,500 shares Expires 2031-06-10 F1 · security: Pursuant to Omeros Corporation's non-employee director compensation policy, on the date of each annual meeting of shareholders, each non-employee director who has served as a director for at least six months and who will continue to serve as a director after the annual meeting is automatically granted an option to purchase 7,500 shares of common stock. This Form 4 reports the annual stock option award granted to the reporting person in conjunction with the annual meeting of shareholders held on June 11, 2021. F2 · derivative.exercise_date: This option will fully vest and become exercisable on the day before the date of the 2022 annual meeting of the shareholders of Omeros Corporation, provided that the participant continues to serve as a director of the company through such date. Read SEC document |
| February 12, 2021 Filed Feb 17, 2021 22:15 UTC | OMEROS CORP OMER · Entity 4756 | Exercise / conversionStock Option (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $4.53 | $0.00 |
DisclosureSEC source: 0001415889-21-000730 · form4-02172021_050202.xml · derivative · entry 2 Hood Leroy E. MD PhD · CIK 0001472162 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,000 shares Expires 2021-05-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: On February 12, 2021, the reporting person paid the exercise price and exercised options to purchase 5,000 shares of the company's common stock. These shares have not been sold and are held for the account of the reporting person. Read SEC document |
| February 12, 2021 Filed Feb 17, 2021 22:15 UTC | OMEROS CORP OMER · Entity 4756 | Exercise / conversionCommon Stock | 5,000 | $4.53 | $22,650.00 |
DisclosureSEC source: 0001415889-21-000730 · form4-02172021_050202.xml · nonDerivative · entry 1 Hood Leroy E. MD PhD · CIK 0001472162 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,390 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 05, 2020 Filed Jun 9, 2020 23:55 UTC | OMEROS CORP OMER · Entity 4756 | GrantStock Option (Right to Buy) · Derivative | 7,500 | $0.00 Strike: $14.66 | $0.00 |
DisclosureSEC source: 0001415889-20-001535 · form4-06092020_070601.xml · derivative · entry 1 Hood Leroy E. MD PhD · CIK 0001472162 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 7,500 shares Expires 2030-06-04 F1 · derivative.exercise_date: This option will fully vest and become exercisable on the day before the date of the 2021 annual meeting of the shareholders of Omeros Corporation, provided that the participant continues to serve as a director of the company through such date. Read SEC document |
| March 13, 2020 Filed Mar 17, 2020 21:25 UTC | OMEROS CORP OMER · Entity 4756 | Exercise / conversionStock Option (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $5.92 | $0.00 |
DisclosureSEC source: 0001415889-20-000797 · form4-03172020_050302.xml · derivative · entry 2 Hood Leroy E. MD PhD · CIK 0001472162 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,000 shares Expires 2020-05-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: On March 13, 2020, the reporting person paid the exercise price and exercised options to purchase 5,000 shares of the company's common stock. These shares have not been sold and are held for the account of the reporting person. The options previously vested and became exercisable in equal installments over a three-year period, with a vesting commencement date of May 28, 2010. Read SEC document |
| March 13, 2020 Filed Mar 17, 2020 21:25 UTC | OMEROS CORP OMER · Entity 4756 | Exercise / conversionCommon Stock | 5,000 | $5.92 | $29,600.00 |
DisclosureSEC source: 0001415889-20-000797 · form4-03172020_050302.xml · nonDerivative · entry 1 Hood Leroy E. MD PhD · CIK 0001472162 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,390 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 14, 2019 Filed Dec 18, 2019 02:40 UTC | OMEROS CORP OMER · Entity 4756 | Exercise / conversionStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $7.56 | $0.00 |
DisclosureSEC source: 0000899243-19-029502 · doc4.xml · derivative · entry 2 Hood Leroy E. MD PhD · CIK 0001472162 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,000 shares Expires 2019-12-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: On December 14, 2019, the reporting person paid the exercise price and exercised options to purchase 10,000 shares of the company's common stock. These shares have not been sold and are held for the account of the reporting person. The options previously vested and became exercisable in equal annual installments over a three-year period, with a vesting commencement date of December 15, 2010. Read SEC document |
| December 14, 2019 Filed Dec 18, 2019 02:40 UTC | OMEROS CORP OMER · Entity 4756 | Exercise / conversionCommon Stock | 10,000 | $7.56 | $75,600.00 |
DisclosureSEC source: 0000899243-19-029502 · doc4.xml · nonDerivative · entry 1 Hood Leroy E. MD PhD · CIK 0001472162 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,390 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 07, 2019 Filed Jun 11, 2019 22:57 UTC | OMEROS CORP OMER · Entity 4756 | GrantStock Option (Right to Buy) · Derivative | 7,500 | $0.00 Strike: $16.87 | $0.00 |
DisclosureSEC source: 0000899243-19-016497 · doc4.xml · derivative · entry 1 Hood Leroy E. MD PhD · CIK 0001472162 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 7,500 shares Expires 2029-06-06 F1 · derivative.exercise_date: This option will fully vest and become exercisable on the day before the date of the 2020 annual meeting of the shareholders of Omeros Corporation, provided that the participant continues to serve as a director of the company through such date. Read SEC document |
| June 15, 2018 Filed Jun 18, 2018 20:35 UTC | OMEROS CORP OMER · Entity 4756 | GrantStock Option (Right to Buy) · Derivative | 7,500 | $0.00 Strike: $19.91 | $0.00 |
DisclosureSEC source: 0000899243-18-017010 · doc4.xml · derivative · entry 1 Hood Leroy E. MD PhD · CIK 0001472162 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 7,500 shares Expires 2028-06-14 F1 · derivative.exercise_date: This option will fully vest and become exercisable on the day before the date of the 2019 annual meeting of the shareholders of Omeros Corporation, provided that the participant continues to serve as a director of the company through such date. Read SEC document |
| June 16, 2017 Filed Jun 17, 2017 00:01 UTC | OMEROS CORP OMER · Entity 4756 | GrantStock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $23.75 | $0.00 |
DisclosureSEC source: 0000899243-17-016624 · doc4.xml · derivative · entry 1 Hood Leroy E. MD PhD · CIK 0001472162 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2027-06-15 F1 · derivative.exercise_date: This option will fully vest and become exercisable on the day before the date of the 2018 annual meeting of the shareholders of Omeros Corporation, provided that the participant continues to serve as a director of the company through such date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.